Filing Flows › Healthstream (HSTM) › R&D spending
Healthstream (HSTM) R&D spending by quarter
Healthstream's R&D spending was $13.5M in Q3 2026 (third quarter 2026), -0.4% from Q2 2026. Over the last 7 quarters it ranged from $12.0M (Q1 2025) to $14.8M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $13.5M | -0.4% | +12% |
| Q2 2026 | $13.6M | -0.2% | +12% |
| Q1 2026 | $13.6M | -8% | +13% |
| Q4 2025 | $14.8M | +22% | — |
| Q3 2025 | $12.1M | +0.3% | — |
| Q2 2025 | $12.1M | +0.2% | — |
| Q1 2025 | $12.0M | — | — |
Q3 2026 at a glance
Healthstream, Q3 2026: revenue $83.3M (+9% year over year), operating margin 7.9%, net earnings $5.4M, operating cash flow $17.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Healthstream's R&D spending?
Healthstream's R&D spending was $13.5M in Q3 2026 (third quarter 2026), -0.4% from Q2 2026.
How has Healthstream's R&D spending changed?
Over the last 7 quarters it ranged from $12.0M (Q1 2025) to $14.8M (Q4 2025).